The estimated Net Worth of Kim Sablich is at least $5.57 Milhão dollars as of 8 March 2023. Ms Sablich owns over 3,013 units of Jazz Pharmaceuticals plc stock worth over $3,212,773 and over the last 6 years she sold JAZZ stock worth over $1,487,614. In addition, she makes $869,483 as Exec. VP & GM of North America at Jazz Pharmaceuticals plc.
Ms has made over 6 trades of the Jazz Pharmaceuticals plc stock since 2019, according to the Form 4 filled with the SEC. Most recently she sold 3,013 units of JAZZ stock worth $421,037 on 8 March 2023.
The largest trade she's ever made was selling 4,840 units of Jazz Pharmaceuticals plc stock on 15 January 2020 worth over $67,954. On average, Ms trades about 937 units every 62 days since 2018. As of 8 March 2023 she still owns at least 30,560 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Ms Sablich stock trades at the bottom of the page.
Kim Sablich is the Exec. VP & GM of North America at Jazz Pharmaceuticals plc.
As the Exec. VP & GM of North America of Jazz Pharmaceuticals plc, the total compensation of Ms Sablich at Jazz Pharmaceuticals plc is $869,483. There are 9 executives at Jazz Pharmaceuticals plc getting paid more, with Bruce Cozadd having the highest compensation of $14,713,600.
Ms Sablich is 52, she's been the Exec. VP & GM of North America of Jazz Pharmaceuticals plc since . There are 20 older and 7 younger executives at Jazz Pharmaceuticals plc. The oldest executive at Jazz Pharmaceuticals plc is Catherine Sohn, 67, who is the Independent Director.
Kim's mailing address filed with the SEC is 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, L2, .
Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright, eJp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: